title: Mitochondrial abnormalities of muscle tissue in mice with juvenile visceral steatosis associated with systemic carnitine deficiency.
abstract: A mouse with juvenile visceral steatosis (the JVS mouse) has been recognized as a novel animal model for systemic carnitine deficiency. We examined cardiac, skeletal and smooth muscle cells in JVS and control mice by light and electron microscopy. Cardiac and skeletal muscle cells of these mice at 4 weeks of age exhibited a ragged-red appearance after trichrome staining. Electron microscopy, demonstrated increased numbers of mitochondria and lipid droplets in the cells. Compression or distortion of the myofibril bundles, primarily due to the increased number of mitochondria, suggests the possible existence of a functional disturbance of the cardiac and skeletal muscle. In the urinary bladder, only one or two large lipid droplets and slightly increased number of mitochondria were recognized in the perinuclear region of the smooth muscle cells. At 8 weeks of age, the mouse enzyme histochemistry specific for mitochondria, such as cytochrome c oxidase and succinic dehydrogenase, and oil red O staining, confirmed further increases in the number of mitochondria and lipid droplets in the heart. However, the accumulation of these organelles in the skeletal and smooth muscle cells was no greater than that noted in JVS mice at 4 weeks of age. In the cardiac muscle cells, autolysosomes or autophagic vacuoles containing electron-dense membranous, lamellar or whorled structures closely associated with mitochondria and pseudoinclusion bodies in the nucleus were recognized, and bundles of myofibrils were buried under numerous mitochondria, suggesting the existence of disturbed contractile function in the heart of JVS mice. These results indicate that this murine strain associated with systemic carnitine deficiency exhibits a generalized mitochondrial abnormality in the muscle system especially in the heart.
authors.affiliation: Second Department of Internal Medicine, Osaka University Medical School, Suita, Japan.
authors.forename: J
authors.initials: J
authors.lastname: Miyagawa
authors.forename: M
authors.initials: M
authors.lastname: Kuwajima
authors.forename: T
authors.initials: T
authors.lastname: Hanafusa
authors.forename: K
authors.initials: K
authors.lastname: Ozaki
authors.forename: H
authors.initials: H
authors.lastname: Fujimura
authors.forename: A
authors.initials: A
authors.lastname: Ono
authors.forename: R
authors.initials: R
authors.lastname: Uenaka
authors.forename: I
authors.initials: I
authors.lastname: Narama
authors.forename: T
authors.initials: T
authors.lastname: Oue
authors.forename: K
authors.initials: K
authors.lastname: Yamamoto
mesh_terms: D000818:Animals; D002331:Carnitine / Q000172:deficiency*; D005234:Fatty Liver / Q000139:chemically induced / Q000473:pathology*; D006951:Hyperlipoproteinemias / Q000139:chemically induced / Q000473:pathology*; D051379:Mice; D008817:Mice, Mutant Strains; D008854:Microscopy, Electron; D008929:Mitochondria, Heart / Q000473:pathology*; D018482:Muscle, Skeletal / Q000473:pathology / Q000648:ultrastructure; D009132:Muscles / Q000473:pathology* / Q000648:ultrastructure*; D009206:Myocardium / Q000473:pathology / Q000648:ultrastructure
chemical_list: D002331:Carnitine